Načítá se...

Low-Dose Treatment with Erythropoiesis-Stimulating Agents and Cardiovascular Geometry in Chronic Kidney Disease: Is Darbepoetin-α More Effective than Expected?

INTRODUCTION: Chronic kidney disease (CKD) is a widespread invalidating condition, leading to erythropoietin deficiency and decreased cardiovascular performance. Darbepoetin-α and epoetin-α are extensively used to correct renal anemia. The aim of this study was to evaluate cardiological outcomes in...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Di Lullo, Luca, Floccari, Fulvio, Granata, Antonio, Malaguti, Moreno
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger AG 2012
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3318933/
https://ncbi.nlm.nih.gov/pubmed/22493599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000334942
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!